Raptis Lampros, Pappas Georgios, Katsanou Andromahi, Koutsouka Freideriki, Petrakis Dimitrios, Akritidis Nikolaos
Department of Internal Medicine, General Hospital G. Hatzikosta, Ioannina, Greece.
Pharmacotherapy. 2007 Apr;27(4):600-2. doi: 10.1592/phco.27.4.600.
A 68-year-old woman developed eosinophilic pleural effusion and systemic eosinophilia 2 months after starting antihypertensive therapy with diltiazem. Several drugs are known to cause this disorder; however, the only other drug the patient had been taking was clonidine, which she had taken for the past 3-4 years. She was evaluated for all other possible causes of eosinophilia and eosinophilic pleural effusion, including malignancy, infection, and autoimmune disorders. Her symptoms resolved after diltiazem was discontinued, and no recurrence was noted on follow-up. To our knowledge, this is the first case report of eosinophilic pleural effusion caused by diltiazem. According to the Naranjo adverse drug reaction probability scale, a probable relationship existed between diltiazem and the patient's eosinophilia and pleural effusion. Although numerous drugs have been associated with eosinophilia and eosinophilic pleural effusion, the spectrum may actually be wider than is commonly thought and may include such unrecognized agents as diltiazem.
一名68岁女性在开始使用地尔硫䓬进行抗高血压治疗2个月后出现嗜酸性粒细胞性胸腔积液和全身性嗜酸性粒细胞增多。已知有几种药物会导致这种疾病;然而,该患者一直在服用的唯一其他药物是可乐定,她已经服用了3 - 4年。对她进行了针对嗜酸性粒细胞增多和嗜酸性粒细胞性胸腔积液的所有其他可能病因的评估,包括恶性肿瘤、感染和自身免疫性疾病。停用 地尔硫䓬后她的症状得到缓解,随访期间未发现复发。据我们所知,这是地尔硫䓬引起嗜酸性粒细胞性胸腔积液的首例病例报告。根据纳兰霍药物不良反应概率量表,地尔硫䓬与患者的嗜酸性粒细胞增多和胸腔积液之间可能存在关联。尽管有许多药物与嗜酸性粒细胞增多和嗜酸性粒细胞性胸腔积液有关,但实际范围可能比通常认为的更广,可能包括像地尔硫䓬这样未被认识的药物。